Raser Jeffrey 4
4 · Somaxon Pharmaceuticals, Inc. · Filed Apr 5, 2010
Insider Transaction Report
Form 4
Raser Jeffrey
Senior VP, Sales and Marketing
Transactions
- Award
Common Stock
2010-04-01+40,000→ 55,000 total - Award
Stock option (right to buy)
2010-04-01+150,000→ 150,000 totalExercise: $8.59Exp: 2020-03-31→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]These shares are represented by restricted stock units ("RSUs"). 1/3 of these RSUs will vest upon the first date included within an open trading window under the Company's Insider Trading Policy following the first commercial sale of Silenor(R) in the United States, 1/3 of these RSUs will vest on 1/1/2012 and 1/3 of these RSUs will vest on 1/1/2013, subject to the reporting person's continued service to the Company through each such vesting date.
- [F2]1/4 of the total number of shares of common stock subject to the option vest on 4/1/2011, and 1/36th of the total remaining number of shares of common stock subject to the option vest on the first day of each calendar month thereafter, subject to the reporting person's continued service to the Company through each such vesting date.
- [F3]Not applicable.